Paola Rogliani
Università degli Studi di Roma Tor Vergata
H-index: 54
Europe-Italy
Top articles of Paola Rogliani
Mortality and Incidence of Acute Exacerbations in the Era of Anti-Fibrotic Agents in Idiopathic Pulmonary Fibrosis: Preliminary Results of a Multi-Center, Prospective Cohort …
2024/5
Burden of Uncontrolled Severe Asthma With and Without Elevated Type-2 Inflammatory Biomarkers
The Journal of Allergy and Clinical Immunology: In Practice
2024/4/1
William Cook
H-Index: 25
Christer Janson
H-Index: 59
Timothy Harrison
H-Index: 2
Ian Pavord
H-Index: 79
David Price
H-Index: 11
Adnan Azim
H-Index: 6
Joshua Kim
H-Index: 5
Paul Thomas
H-Index: 15
Alan Bell
H-Index: 23
Chen Wang
H-Index: 22
Yan Chen
H-Index: 22
Wei Gu
H-Index: 17
Shiyue Li
H-Index: 1
Weidong Song
H-Index: 15
Wei Tan
H-Index: 5
Yijun Tang
H-Index: 9
Tan Wang
H-Index: 2
Feng Wu
H-Index: 9
Jinghua Yang
H-Index: 5
Min Zhang
H-Index: 21
Ping Zhang
H-Index: 3
Wei Zhang
H-Index: 23
Dan Zhu
H-Index: 18
Use of human airway smooth muscle in vitro and ex vivo to investigate drugs for the treatment of chronic obstructive respiratory disorders
2024/3
Mario Cazzola
H-Index: 76
Paola Rogliani
H-Index: 37
Bronchospasm and iodinated contrast media (ICM): an accurate evaluation is mandatory
European annals of allergy and clinical immunology
2024/3
Matteo Martini
H-Index: 11
Paola Rogliani
H-Index: 37
The Impact of Thermal Water in Asthma and COPD: A Systematic Review According to the PRISMA Statement
2024/2/14
Nicola Di Daniele
H-Index: 30
Marco Vitale
H-Index: 42
Mario Cazzola
H-Index: 76
Paola Rogliani
H-Index: 37
Why is Pet (cat/dog) allergen immunotherapy (ait) such a controversial topic? current perspectives and future directions.
2024/2/13
Cardiovascular Events with the Use of Long-Acting Muscarinic Receptor Antagonists: An Analysis of the FAERS Database 2020–2023
Lung
2024/2/6
Paola Rogliani
H-Index: 37
Mario Cazzola
H-Index: 76
Biologics for asthma and risk of pneumonia
Journal of Asthma
2024/1/29
Paola Rogliani
H-Index: 37
Mario Cazzola
H-Index: 76
Pharmacological Interpretation of the Efficacy of Ensifentrine in Chronic Obstructive Pulmonary Disease: Insights from ENHANCE Trials
American Journal of Respiratory and Critical Care Medicine
2024/1/15
Mario Cazzola
H-Index: 76
Paola Rogliani
H-Index: 37
Spontaneous Ventilation Thoracoscopic Lung Biopsy in Undetermined Interstitial Lung Disease: Systematic Review and Meta-Analysis
2024/1/10
Stefano Elia
H-Index: 17
Paola Rogliani
H-Index: 37
Exercise-Induced Asthma: Managing Respiratory Issues in Athletes
2024/1/3
Mario Cazzola
H-Index: 76
Paola Rogliani
H-Index: 37
Investigational thymic stromal lymphopoietin inhibitors for the treatment of asthma: a systematic review
2024/1/2
Paola Rogliani
H-Index: 37
The impact of psychological health in African American young adults on asthma control: why is phenotyping still an unmet need? Suggestions from a multidisciplinary ‘Stress …
Journal of Asthma
2024/1/2
Matteo Martini
H-Index: 11
Paola Rogliani
H-Index: 37
Clinical challenges in applying the new lung function test interpretive strategies: navigating pitfalls and possible solutions
European Respiratory Journal
2024/1/1
Paola Rogliani
H-Index: 37
Systematic literature review of treatments used for refractory or unexplained chronic cough in adults
2024/1/1
Paola Rogliani
H-Index: 37
Aidan Byrne
H-Index: 4
Exacerbation Burden in COPD and Occurrence of Mortality in a Cohort of Italian Patients: Results of the Gulp Study
International Journal of Chronic Obstructive Pulmonary Disease
2024/12/31
Fulvio Braido
H-Index: 35
Marco Contoli
H-Index: 27
Paola Rogliani
H-Index: 37
Laura Saderi
H-Index: 15
Giovanni Sotgiu
H-Index: 55
Tozorakimab. Anti-IL-33 monoclonal antibody, Treatment of COPD and asthma, Treatment of atopic dermatitis, Treatment of diabetic kidney disease
Drugs of the Future
2023
Mario Cazzola
H-Index: 76
Paola Rogliani
H-Index: 37
Assessing the relationship between cardiovascular and small airway disease and acute events in COPD: The ARCADIA study protocol
Pulmonary Pharmacology & Therapeutics
2023/10/1
Paola Rogliani
H-Index: 37
The level of ICS in BDP/FF/GB modulates inflammation in a human ex vivo model of severe eosinophilic asthma
2023/9/9
Paola Rogliani
H-Index: 37
Long-term effectiveness of benralizumab in severe eosinophilic asthma patients treated for 96-weeks: data from the ANANKE study
Respiratory Research
2023/5/20
Co-Authors
